Comparative Study of Intravaginal Metronidazole and Triple-Sulfa Therapy for Bacterial Vaginosis
1996

Comparing Metronidazole Gel and Triple-Sulfa Cream for Bacterial Vaginosis

Sample size: 247 publication Evidence: moderate

Author Information

Author(s): Jack D. Sobel, Walter Chaim, Jessica Thomason, Charles Livengood, Richard Sweet, James A. McGregor, David Eschenbach, Sharon Hillier, Rudolph Galask, Sebastian Faro, Elizabeth Shangle, David Baker

Primary Institution: Wayne State University School of Medicine

Hypothesis

Is metronidazole gel more effective than triple-sulfa cream in treating bacterial vaginosis?

Conclusion

Metronidazole gel is a safe, effective, and well-tolerated treatment for bacterial vaginosis.

Supporting Evidence

  • At the final visit, 66% of patients treated with metronidazole remained cured compared to 47% of those treated with triple-sulfa.
  • Metronidazole was statistically superior in eliminating 3 of the 4 criteria for bacterial vaginosis at the final visit.
  • The clinical diagnosis had a high correlation (88%) with independent assessments by Gram's stain.

Takeaway

This study looked at two treatments for a vaginal infection called bacterial vaginosis. It found that one treatment, metronidazole gel, worked better than the other, triple-sulfa cream.

Methodology

A double-blinded study where 247 women with symptomatic bacterial vaginosis were randomly assigned to receive either metronidazole gel or triple-sulfa cream for 5 days.

Limitations

The study had a high dropout rate and included a population with a history of recurrent bacterial vaginosis.

Participant Demographics

Nonpregnant women, 18 years or older, with a mean age of 30.6 years; 47% white and 47% black.

Statistical Information

P-Value

0.02

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication